Effectiveness of Cortiment® in Patients With Ulcerative Colitis

Inclusion Criteria: * Men and women aged ≥ 18 years * Outpatients * Patients who have been prescribed Cortiment® for the treatment of mild to moderate active ulcerative colitis within a 5 days' time window prior to being included in the study * Patients who have received adequate information regarding this non-interventional study and are able to understand and voluntarily sign the Informed Consent Exclusion Criteria: * Patients with severe active / fulminant ulcerative colitis * Patients treated with antibiotics or corticosteroids for the current flare. Use of Antibiotics for other conditions non-related to the gastrointestinal tract, either before enrolment or during the observational period is permitted. * History of total / sub-total colectomy * Hypersensitivity to the active substance, lecithin (derived soya oil, peanut oil) or to any of the excipients * Patients enrolled and involved in an interventional study * Patients whom investigators consider inappropriate to participate in the study